Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Beck

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Science (New York, N.Y.)|October 23, 2020
Susceptibility to severe COVID-19David B Beck, Ivona Aksentijevich
Current Protocols in Chemical Biology|June 20, 2017
Photoactivated In Vivo Proximity LabelingDavid B Beck, Roberto Bonasio
Frontiers in Immunology|February 16, 2019
Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic DiseaseDavid B Beck, Ivona Aksentijevich
Rheumatology (Oxford, England)|January 25, 2025
Improving outcomes in VEXAS syndrome: the need for prospective dataJerome Hadjadj, David B Beck
Nature Reviews. Rheumatology|June 6, 2025
Clonal dominance: mutations in VEXAS syndrome take advantage of inflammationSamuel J Magaziner, David B Beck
Cell Death and Differentiation|December 18, 2020
Deubiquitylases in developmental ubiquitin signaling and congenital diseasesMohammed A Basar, David B Beck, Achim Werner
Experimental Cell Research|September 28, 2020
Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease geneticsAnthony J Asmar, David B Beck, Achim Werner
Annual Review of Pathology|October 13, 2023
Clonal Hematopoiesis, Inflammation, and Hematologic MalignancyRashmi Kanagal-Shamanna, David B Beck, Katherine R Calvo
The New England Journal of Medicine|June 2, 2021
Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. ReplyDavid B Beck, Peter C Grayson, Daniel L Kastner
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2021
VEXAS syndrome with systemic lupus erythematosus: expanding the spectrum of associated conditionsAman Sharma, Gsrsnk Naidu, Prateek Deo, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Science (New York, N.Y.)|October 23, 2020
Susceptibility to severe COVID-19David B Beck, Ivona Aksentijevich
Current Protocols in Chemical Biology|June 20, 2017
Photoactivated In Vivo Proximity LabelingDavid B Beck, Roberto Bonasio
Frontiers in Immunology|February 16, 2019
Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic DiseaseDavid B Beck, Ivona Aksentijevich
Rheumatology (Oxford, England)|January 25, 2025
Improving outcomes in VEXAS syndrome: the need for prospective dataJerome Hadjadj, David B Beck
Nature Reviews. Rheumatology|June 6, 2025
Clonal dominance: mutations in VEXAS syndrome take advantage of inflammationSamuel J Magaziner, David B Beck
Cell Death and Differentiation|December 18, 2020
Deubiquitylases in developmental ubiquitin signaling and congenital diseasesMohammed A Basar, David B Beck, Achim Werner
Experimental Cell Research|September 28, 2020
Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease geneticsAnthony J Asmar, David B Beck, Achim Werner
Annual Review of Pathology|October 13, 2023
Clonal Hematopoiesis, Inflammation, and Hematologic MalignancyRashmi Kanagal-Shamanna, David B Beck, Katherine R Calvo
The New England Journal of Medicine|June 2, 2021
Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. ReplyDavid B Beck, Peter C Grayson, Daniel L Kastner
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2021
VEXAS syndrome with systemic lupus erythematosus: expanding the spectrum of associated conditionsAman Sharma, Gsrsnk Naidu, Prateek Deo, et al.
Pageof 9